| Success Stories | | Print | |
|
Awards in Excellence Every year, the PhRMA Foundation grants Awards in Excellence to past awardees who are dramatic, living proof that the Foundation program works and makes a difference. These awards are given to scientists who received a Foundation grant at the outset of their careers in a discipline important to the research-based pharmaceutical industry when they were deciding on their area of specialization and went on to distinguish themselves through their scientific and/or academic achievements. This year's two awardees have distinguished themselves in the areas of pharmacology/toxicology and clinical pharmacology. The Foundation is proud of their achievements and is proud to have been of assistance to them at the beginning of their outstanding careers. They exemplify the very best in their chosen fields. What they have achieved makes it easier to appreciate the importance of providing the same kind of support to those who follow in their footsteps.
2010 Award in Excellence in Pharmacology/Toxicology Roger A. Nicoll, M.D.
2010 Award in Excellence in Clinical Pharmacology Raymond L. Woosley, M.D., Ph.D. Raymond Woosley, M.D., Ph.D. is the Chairman of the Board and President & CEO of the Critical Path Institute (C-Path). Prior to this position, he was Vice President for Health Sciences at the University of Arizona. C-Path is a non-profit partnership between the UA, SRI International (formerly Stanford Research Institute) and the U.S. Food and Drug Administration. Its goal is to facilitate research and educational programs conducted by UA faculty that will enable the FDA and the pharmaceutical industry to accelerate the development of safe new therapies. Dr. Woosley is a noted medical administrator, scholar and researcher with special interests in the safe use of medications. Before joining the University of Arizona, Dr. Woosley was Associate Dean for Clinical Research at Georgetown University and also had served as chair of Georgetown's Department of Pharmacology, 1988-2000. During his tenure, that department became one of the highest ranked pharmacology departments in terms of research funding, and achieved the largest endowment of any pharmacology department in the nation. Prior to Georgetown, Dr. Woosley was professor of Medicine and Pharmacology at Vanderbilt University Medical School in Nashville, Tenn. Before that, he was one of the first scientists at Meyer Laboratories (now GlaxoSmithKline) from 1968-71. While at Vanderbilt, Dr. Woosley provided important evidence about the importance of cytochrome P450 2D6 in relationship to the use of antiarrhythmic drugs. Also he chaired the Data Safety Monitoring Committee for the famed CAST trial that showed that antiarrhythmic drugs are deleterious in the treatment of ventricular arrhythmias post myocardial infarction rather than helpful. While at Georgetown he contributed substantially to understanding that noncardiovascular drugs may have cardiovascular effects, findings that led to withdrawal of terfenadine (Seldane) and several other drugs from the market. As an offshoot of this he championed the development of Centers of Excellence in Research and Therapeutics (CERTS), now funded by the government, that are designed to improve efforts at postmarketing surveillance of drugs. Among many other honors and awards, Dr. Woosley recently received the Harry Gold Award in Therapeutics from the American Society for Pharmacology and Experimental Therapeutics and was the Sir Henry Hallet Dale Visiting Professorship in Clinical Pharmacology at Johns Hopkins University School of Medicine. He was the recipient of the FDA Commission's Special Citation for his work with the FDA to make the public and Congress aware of the dangers associated with certain dietary supplements containing the herbal medicine, ephedrine. He often has been chosen by physician-colleagues for inclusion in the Best Doctors in America. He is a member of numerous advisory committees for the National Institutes of Health and the Department of Veterans Affairs, as well as a number of other research advisory groups, including the WebMD Medical Advisory Board and the Board of the Society for Women's Health Research. He has served on the editorial boards for numerous medical and pharmacology journals. Dr. Woosley received his medical degree from the University of Miami, a doctorate in pharmacology from the University of Louisville and his bachelor's degree from Western Kentucky University. He served his internship and residency in internal medicine -- and also completed a fellowship in clinical pharmacology -- at Vanderbilt. |
(C) 2010 PhRMA Foundation - 950 F Street, N.W. Suite 300 Washington, DC 20004